AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 203 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,334,000 | +18.3% | 87,132 | +7.9% | 0.13% | +18.5% |
| Q1 2022 | $1,128,000 | +1609.1% | 80,750 | +100.9% | 0.11% | +1700.0% |
| Q4 2021 | $66,000 | -84.4% | 40,200 | -71.3% | 0.01% | -72.7% |
| Q2 2021 | $424,000 | +100.9% | 140,151 | +209.4% | 0.02% | +57.1% |
| Q1 2021 | $211,000 | +137.1% | 45,300 | +126.5% | 0.01% | +75.0% |
| Q4 2020 | $89,000 | +107.0% | 20,000 | +100.0% | 0.01% | +100.0% |
| Q4 2019 | $43,000 | -95.9% | 10,000 | -85.5% | 0.00% | -98.5% |
| Q3 2019 | $1,042,000 | – | 69,052 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |